March 27th Options Now Available For TJX

TJX (current price $155.90) option strategies highlighted: selling a $140 put (bid $0.31) would set an effective purchase basis of $139.69 and is reported to have an 83% chance of expiring worthless, yielding 0.22% (1.62% annualized) if so. A covered-call at the $160 strike (bid $1.71) would cap upside at $160 but generate a 3.73% total return if called by March 27, with a 60% chance of expiring worthless and a 1.10% (8.01% annualized) YieldBoost; implied volatilities are 33% (put) and 23% (call) versus a 12‑month trailing volatility of 18%.

Analysis

Market structure: The options flow and IV skew (puts IV 33% vs calls 23% vs realized 18%) signal asymmetric downside protection demand for TJX (ticker: TJX). Short-dated OTM put sellers are being paid a trivial yield (0.22% absolute, 1.62% annualized) to commit capital ~10% below spot; that implies market consensus that large downside is low-probability (~17% over the contract life) but priced with a material premium versus realized vol. For dealers/market-makers this is a small net supply of risk capacity that can be monetized via delta-hedging and calendar trades.

Risk assessment: Near-term (days–weeks) the primary risks are macro shocks (worse-than-expected CPI/jobs) or an earnings surprise that re-prices retail; both would widen put IV and could make $140 assignment more likely. Medium-term (1–6 months) inventory and margin mix changes are the second-order risks; long-term (12–36 months) secular retail share shifts and international execution matter. Hidden dependencies include consumer credit trends and promotional intensity from peers (ROST, BJ, COST), which can quickly compress off-price spreads.

Trade implications: For income-oriented allocation, use cash-secured sell-to-open TJX Mar27 $140 puts size-limited to 1–2% portfolio (max 200 shares) with the intent to acquire at $139.69; if filled, hold 3–12 months unless fundamentals deteriorate. For active equity exposure, buy 100 TJX and sell the Mar27 $160 call (covered call) to capture ~1.10% premium (8.0% annualized), rolling up if stock >$160 by 3–5% pre-expiry. To express view on skew, consider a defined-risk put spread: sell $140 / buy $130 Mar27 to collect higher net credit while capping tail loss.

Contrarian angles: Consensus underweights the chance that TJX can continue to outcompete peers via inventory agility; if same-store sales beat by >2% over two quarters, the current covered-call cap (~3.7% to $160) will be clearly underpriced. Conversely, the market may be underpricing a shallow recession: a >5% drop in consumer discretionary consumption would blow out puts and make selling naked puts poor risk-adjusted trade. Historical parallels (post-2015 off-price leadership) show large drawdowns are recoverable over 6–18 months; manage size and use defined-risk structures rather than naked short gamma.

Key Decisions for Investors

• Sell cash-secured TJX Mar27 $140 put (collect ~$0.31) sized to 1%–2% of portfolio (100–200 shares equivalent). Target effective basis $139.69; if assigned, plan to hold 3–12 months and trim only if TJX < $130 within 30 days.
• Establish a covered-call income sleeve: buy 100 TJX at market (~$155.90) and sell Mar27 $160 call for ~$1.71. Limit to 1–3% portfolio; if stock trades >$160 and you want to keep exposure, roll to a later-month call and buy back for up to 50% of premium when intrinsic >50%.
• If you prefer defined risk: sell TJX Mar27 $140 / buy Mar27 $130 put spread to receive net credit while capping tail loss. Size to replace a naked put allocation and keep max loss per spread = $10 strike width less credit.
• Relative-value pair: Long TJX vs short ROST (equal-dollar) 1%–2% portfolio weight, hold 3–6 months. Set stop-loss if spread tightens by 3% absolute or if TJX misses EPS by >3% on next report.